Prescription drug prices in the United States

NATUROPATHICA™ HOLISTIC HEALTH APPOINTS CATHY O'BRIEN AS CHIEF EXECUTIVE OFFICER

Retrieved on: 
Thursday, August 18, 2022

NEW YORK, Aug. 18, 2022 /PRNewswire/ -- Naturopathica™, the leading holistic beauty and wellbeing company for natural and responsible skincare and body care, announces the appointment of Cathy O'Brien as Chief Executive Officer. As CEO, O'Brien will be responsible for accelerating Naturopathica™'s growth in the clean beauty and wellness space, driving product innovation, expanding into new channels and markets, and continuing to build on the brand's industry-leading spas and healing centers.

Key Points: 
  • NEW YORK, Aug. 18, 2022 /PRNewswire/ -- Naturopathica, the leading holistic beauty and wellbeing company for natural and responsible skincare and body care, announces the appointment of Cathy O'Brien as Chief Executive Officer.
  • O'Brien has served in numerous leadership roles in the ultra-competitive and continually changing entertainment and beauty industries.
  • She brings more than 25 years of experience building businesses, identifying and launching emerging talent to worldwide success.
  • Naturopathicais a skincare and body care brand famed for its use of naturopathic healing rituals and its holistic approach to beauty and well-being.

'What the Health?': The Drug Price Dilemma

Retrieved on: 
Friday, July 30, 2021

That is because the dilemma faced by many Americans is the struggle of paying the price for filling their prescriptions.

Key Points: 
  • That is because the dilemma faced by many Americans is the struggle of paying the price for filling their prescriptions.
  • Among other G7 nations the UK, France, and Italy have the lowest prescription drug prices.
  • Canada's drug prices are higher, but still considerably less than the cost for the same medications in the USA.
  • That improved access has yet to be seen, and so the dilemma of figuring out ways to afford prescription medication continues for many Americans.

Fighting the Rising Costs of Prescription Drugs with One Powerful Coupon: RxGo and WithHealth Announce Partnership, Granting Access to Thousands of Prescription Drug Discounts for Telehealth Patients

Retrieved on: 
Wednesday, July 7, 2021

"We're extremely happy to work with WithHealth, enabling us to reach a growing range of clients who need our help," said Jeremy Duboys, Founder of RxGo.com.

Key Points: 
  • "We're extremely happy to work with WithHealth, enabling us to reach a growing range of clients who need our help," said Jeremy Duboys, Founder of RxGo.com.
  • "Our mission has always been to save patients as much as possible on the continually rising costs of prescription medications.
  • "WithHealth is pleased to be working with RxGo to reduce prescription costs for employers and their employees.
  • Learn more at: www.withhealth.com
    Founded in 2012, RxGo.com offers discounts on prescription drugs to those who need it most.

Xevant Launches Game-Changing Drug Rebate Solution, RebateLogic

Retrieved on: 
Tuesday, June 29, 2021

Xevant's new module dramatically lowers drug costs and improves rebate yields.

Key Points: 
  • Xevant's new module dramatically lowers drug costs and improves rebate yields.
  • RebateLogic automatically analyzes prescription claims data to identify opportunities to optimize utilization, formulary, and rebate management while leveraging industry-best rebate pricing.
  • We've set out to achieve the lowest possible drug cost and that's what RebateLogic gives us the ability to do."
  • RebateLogic is revolutionizing the healthcare industry by ensuring drug rebates do what they are supposed to -- deliver the lowest net prescription cost without compromising patient health.

LowerMyRx Has Saved Patients Millions on Medication Purchases

Retrieved on: 
Thursday, June 24, 2021

MOUNT LAUREL, N.J., June 24, 2021 /PRNewswire/ -- LowerMyRx, a nationwide prescription discount program, announced today that their free service has been able to save patients millions of dollars on medication purchases over the past eightyears.

Key Points: 
  • MOUNT LAUREL, N.J., June 24, 2021 /PRNewswire/ -- LowerMyRx, a nationwide prescription discount program, announced today that their free service has been able to save patients millions of dollars on medication purchases over the past eightyears.
  • LowerMyRx helps consumers search and compare discounted medication prices, saving patients up to 80% at thousands of pharmacies nationwide.
  • Whether it be blood pressure medication or cholesterol-lowering medication, patients can search for discounts on LowerMyRx.com and save.
  • Lowering medication costs since 2013, LowerMyRx strives to help as many patients as possible and make medication affordable for all.

TELUS Health Drug Trends report: Acute medication claims declined in early months of pandemic

Retrieved on: 
Wednesday, June 9, 2021

As a partner to the health benefits community, we remain committed to introducing innovative tools and practices to continue supporting improved employee health.

Key Points: 
  • As a partner to the health benefits community, we remain committed to introducing innovative tools and practices to continue supporting improved employee health.
  • Published annually since 2015, the TELUS Health Drug Trends and National Benchmarks Report considers major trends in private drug plan costs, utilization, and benefits plan management.
  • It provides a snapshot of the previous year, exploring trends in drug claims activities for more than 13 million insured Canadians across 150 million prescription drug claims.
  • TELUS Health is a leader in digital health technology, providing virtual care, home health monitoring, electronic medical and health records, benefits and pharmacy management, and personal emergency response services.

Suggested Reasons for Price of Prescription Drugs in America

Retrieved on: 
Tuesday, June 1, 2021

High prescription medication costs are a harsh reality for the average American, and these days relief from paying high costs for life-saving medication is needed more than ever.

Key Points: 
  • High prescription medication costs are a harsh reality for the average American, and these days relief from paying high costs for life-saving medication is needed more than ever.
  • Big pharma always insists there are legitimate reasons why Rx medications are so expensive, but many of them aren't legitimized.
  • Although this holds to be true, profits generated from selling prescription medication cover for those costs and produce tidy profits.
  • In America, companies have patents on their pharmaceuticals, and while the patents are still in place, the prescription medications can be valued at whatever price point they think is best.

88 Percent Of Older Adults Want Medicare To Negotiate Drug Prices According to New Survey by The Senior Citizens League

Retrieved on: 
Tuesday, May 25, 2021

WASHINGTON, May 25, 2021 /PRNewswire-PRWeb/ --Older Americans overwhelmingly support legislation that would allow Medicare to negotiate prescription drug prices, according to a new survey by The Senior Citizens League (TSCL) .The online survey, which had over 1,234 participants, found that 88 percent support tying prescription drug prices to what other industrialized countries, such as Great Britain, Canada and Japan, pay for the same drug.

Key Points: 
  • WASHINGTON, May 25, 2021 /PRNewswire-PRWeb/ --Older Americans overwhelmingly support legislation that would allow Medicare to negotiate prescription drug prices, according to a new survey by The Senior Citizens League (TSCL) .The online survey, which had over 1,234 participants, found that 88 percent support tying prescription drug prices to what other industrialized countries, such as Great Britain, Canada and Japan, pay for the same drug.
  • The Senior Citizens League supports legislation that would allow Medicare to negotiate drug prices, and limit drug price increases to the rate of inflation.
  • With 1.2 million supporters, The Senior Citizens League is one of the nation's largest nonpartisan seniors groups.
  • The Senior Citizens League is a proud affiliate of The Retired Enlisted Association .

United States Generic Drugs Market Report 2020-2026: Focus on CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Anti-infective & Oncology - ResearchAndMarkets.com

Retrieved on: 
Monday, April 26, 2021

b'The "United States Generic Drugs Market By Segment (Generic, Branded), Therapeutic Application, Company Analysis & Forecast" report has been added to ResearchAndMarkets.com\'s offering.\nUnited States Generic Drugs Market will be US$ 239.5 Billion by 2026.\nGenerics are an off-patented drug that is pharmaceutical equivalents to branded medicines in term of administrative dosage, quality, effect, intended use and side effects.

Key Points: 
  • b'The "United States Generic Drugs Market By Segment (Generic, Branded), Therapeutic Application, Company Analysis & Forecast" report has been added to ResearchAndMarkets.com\'s offering.\nUnited States Generic Drugs Market will be US$ 239.5 Billion by 2026.\nGenerics are an off-patented drug that is pharmaceutical equivalents to branded medicines in term of administrative dosage, quality, effect, intended use and side effects.
  • In the United States, generic drug production has increased because it is cheaper than any branded medicine.
  • In the United States, the decline in medicine price works as the biggest catalyst for the generic drug market growth.
  • These generic medicines prices sometimes declined to 85% less than patented drugs; this happens when various generic drug companies target a single patented drug.

Global Generic Drugs Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecast

Retrieved on: 
Friday, April 16, 2021

b'DUBLIN, April 16, 2021 /PRNewswire/ -- The "Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global generic drugs market reached a value of US$ 386 Billion in 2020.

Key Points: 
  • b'DUBLIN, April 16, 2021 /PRNewswire/ -- The "Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global generic drugs market reached a value of US$ 386 Billion in 2020.
  • A generic drug is a medicine that contains the same active ingredient and has an equivalent therapeutic effect as the branded drug.
  • To address these problems, governments and other regulatory bodies have been encouraging manufacturers to introduce effective generic drugs.
  • The company is producing 14 short-supply, FDA-approved drugs that have been available in the market since the beginning of 2019.